Evidence map›Paper›PMID 40235661›Full record

ArticleFrontiers in endocrinology2025

Cardiometabolic index predicts cardiovascular events in aging population: a machine learning-based risk prediction framework from a large-scale longitudinal study.

Yuanxi Luo, Zhiyang Yin, Xin Li, Chong Sheng, Ping Zhang, Dongjin Wang, Yunxing Xue

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuanxi Luo *Department of Cardiac Surgery, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Graduate School of Peking Union Medical College, Beijing, China.
Zhiyang Yin *School of Pediatrics, Nanjing Medical University, Nanjing, China.
Xin Li *Department of Cardiac Surgery, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Graduate School of Peking Union Medical College, Beijing, China.
Chong ShengDepartment of Cardiac Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Ping ZhangDepartment of Cardiac Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Dongjin WangDepartment of Cardiac Surgery, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Graduate School of Peking Union Medical College, Beijing, China.
Yunxing XueDepartment of Cardiac Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: While the Cardiometabolic Index (CMI) serves as a novel marker for assessing adipose tissue distribution and metabolic function, its prognostic utility for cardiovascular disease (CVD) events remains incompletely understood. This investigation sought to elucidate the predictive capabilities of CMI for cardiovascular outcomes and explore underlying mechanistic pathways to establish a comprehensive risk prediction framework. Methods: The study encompassed 7,822 individuals from a national health and retirement longitudinal cohort, with participants stratified by CMI quartiles. Following baseline characteristic comparisons and CVD incidence rate calculations, we implemented multiple Cox regression models to assess CMI's cardiovascular risk prediction capabilities. For nomogram construction, we utilized an ensemble machine learning framework, combining Boruta algorithm-based feature selection with Random Forest (RF) and XGBoost analyses to determine key predictive parameters. Results: Throughout the median follow-up duration of 84 months, we documented 1,500 incident CVD cases, comprising 1,148 cardiac events and 488 cerebrovascular events. CVD incidence demonstrated a positive gradient across ascending CMI quartiles. Multivariate Cox regression analysis, adjusting for potential confounders, confirmed a significant association between CMI and CVD risk. Notably, mediation analyses revealed that hypertension and glycated hemoglobin (HbA1c) potentially serve as mechanistic intermediaries in the CMI-CVD relationship. Sex-stratified analyses suggested differential predictive patterns between gender subgroups. Given CMI's robust and consistent predictive capability for stroke outcomes, we developed a machine learning-derived nomogram incorporating five key predictors: age, CMI, hypertension status, high-sensitivity C-reactive protein (hsCRP) and renal function (measured as serum creatinine). The nomogram demonstrated strong discriminative ability, achieving areas under the receiver operating characteristic curve (AUC) of 0.76 (95% CI: 0.56-0.97) and 0.74 (95% CI: 0.66-0.81) for 2-year and 6-year stroke prediction, respectively. Conclusions: Our findings establish CMI as a significant predictor of cardiovascular events in the aging population, with the relationship partially mediated through hypertension and insulin resistance pathways. The validated nomogram, developed using longitudinal data from a substantial elderly cohort, incorporates CMI to enable preclinical risk stratification, supporting timely preventive strategies.

Indexed as

AgingCardiovascular DiseasesMachine LearningAgedBiomarkersFemaleFollow-Up StudiesHumansIncidenceLongitudinal StudiesMaleMiddle AgedNomogramsPrognosisRisk AssessmentRisk FactorsBiomarkerscardiometabolic indexcardiovascular diseaseCHARLSmachine learningstroke

Identifiers

PMID40235661
PMCPMC11996631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.